Cytokinetics, Incorporated (NASDAQ:CYTK) Q4 2024 Earnings Call Transcript February 27, 2025
Cytokinetics, Incorporated beats earnings expectations. Reported EPS is $-1.26, expectations were $-1.29.
Operator: Good afternoon, and welcome to Cytokinetics’ Fourth Quarter 2024 Conference Call. At this time, I would like to inform you that this call is being recorded. And all participants are in a listen-only mode. At the company’s request, we will open the call to questions after the...
